NCT02715531 2021-07-09A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid TumorsHoffmann-La RochePhase 1 Completed243 enrolled
NCT01359696 2017-04-12A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or LymphomaGenentech, Inc.Phase 1 Completed40 enrolled